IDEX Biometrics ASA
IDEX.OL · OSL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.92 | 38.52 | 176.11 | -3,531.25 |
| FCF Yield | -0.62% | -0.08% | -0.06% | -0.02% |
| EV / EBITDA | -292.08 | -129.34 | -1,729.31 | -4,985.07 |
| Quality | ||||
| ROIC | -300.33% | -111.95% | -128.50% | -82.31% |
| Gross Margin | -100.24% | 5.58% | 20.72% | 55.85% |
| Cash Conversion Ratio | 1.20 | 1.01 | 0.98 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -40.99% | 13.50% | 55.18% | 161.79% |
| Free Cash Flow Growth | 35.85% | 15.02% | -16.51% | -16.84% |
| Safety | ||||
| Net Debt / EBITDA | -0.04 | 0.02 | 0.15 | 1.13 |
| Interest Coverage | -9.08 | -3.99 | -950.58 | -1,011.29 |
| Efficiency | ||||
| Inventory Turnover | 0.30 | 0.61 | 0.73 | 1.02 |
| Cash Conversion Cycle | 1,422.33 | 618.10 | 530.28 | 357.85 |